SynBioBeta Speaker
Matías Peire
GRIDX
Founder & CEO
Matías Peire is the Founder and CEO of GRIDX, a venture capital fund with a venture builder approach focused on transforming cutting-edge science into high-growth startups —from Latin America to the world.After more than 10 years leading a co-founded company developing new techs (hard + soft) for the broadcast industry, in 2013 started a pathway to discover how to invest in science-based startups when there were no VCs investing. After 3 years of research, mapping hundreds of projects in Argentina and designing a company builder process in 2016 he co-founded GRIDX.Over the past ten years, Matías has led GRIDX in launching more than 90 biotech startups across the region, with a focus on Health, Ag & Food, Bioindustry, and Deep Bio across two funds with $41MM AUM.GRIDX pioneers a model that bridges the gap between Latin America’s scientific ecosystem and the global venture capital industry, partnering with top researchers and entrepreneurs to turn groundbreaking science into globally scalable companies.Passionate about reimagining how venture capital can unlock the potential of emerging science in underserved ecosystems, Matías is helping shape a new generation of biotech founders driven by scientific excellence and global ambition.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Matías
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
